Sort
23,748 grants matching “melanoma”
Cancer Genetics
$310,178Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2015 · CA
SOUTHWEST ONCOLOGY GROUP
$310,163Wayne State University · U10 · FY2000 · CA
The role of a histone H4 phosphorylation in drug resistance
$310,130Zhiguo Zhang · Mayo Clinic Rochester · R01 · FY2013 · CA
Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents
$310,126Paul B Fisher · Virginia Commonwealth University · R01 · FY2009 · CA
Developmental Core
$310,117Jose A Torres-Ruiz · Ponce School Of Medicine · U56 · FY2010 · CA
ANALYSIS OF BMT CONDITIONING, CYTOKINES, GVHD AND GVL
$310,115Dana-Farber Cancer Institute · P01 · FY2000 · CA
Chemically Programmed Antibodies for Cancer Therapy
$310,063Carlos F Barbas · Scripps Research Institute, The · R01 · FY2010 · CA
Chemically Programmed Antibodies for Cancer Therapy
$310,063Carlos F Barbas · Scripps Research Institute, The · R01 · FY2009 · CA
B7-H1 Signaling in Ovarian Cancer
$310,040Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2012 · CA
Role of the EP1 prostanoid receptor in UV carcinogenesis
$309,969Ohio State University · R01 · FY2005 · CA
Antibody-interferon fusion proteins for treatment of B-cell malignancies
$309,964Sherie L Morrison · University Of California Los Angeles · R01 · FY2014 · CA
The 26S Proteasome in Cancer Stem Cells
$309,964Frank Pajonk · University Of California Los Angeles · R01 · FY2011 · CA
Overcoming acute, adaptive BRAF inhibitor resistance in melanoma
$309,964Roger S Lo · University Of California Los Angeles · R01 · FY2014 · CA
Does UV-induced Unconventional Mast Cell Migration Activate Immune Suppression?
$309,964Stephen E Ullrich · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
The 26S Proteasome in Cancer Stem Cells
$309,964Frank Pajonk · University Of California Los Angeles · R01 · FY2012 · CA
Does UV-induced Unconventional Mast Cell Migration Activate Immune Suppression?
$309,964Stephen E Ullrich · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$309,948Elad Ziv · University Of California, San Francisco · R01 · FY2023 · CA
Biology of Melanoma Matastasis
$309,892Wistar Institute · R01 · FY2004 · CA
Biosignature and Vector Development Core
$309,867Gregory M Lanza · Washington University · U54 · FY2009 · CA
CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY
$309,825Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY
$309,825Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA
Epidermal Mechanisms Opposing Ceramide-Induced Apoptosis
$309,771Yoshikazu Uchida · Northern California Institute/Res/Edu · R01 · FY2007 · AR
Targeting scramblase TMEM16F to break T cell exhaustion
$309,750Florian Winau · Boston Children'S Hospital · R21 · FY2018 · AI
BMP7 in melanoma niche morphogenesis and homeostasis
$309,718Mei-Yu Hsu · Boston University Medical Campus · R01 · FY2013 · CA
Targets of Immune-Mediated Tumor Destruction
$309,680Dana-Farber Cancer Institute · R01 · FY2005 · CA